CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The hospital hosted a two-day event with top internal and external faculty and medical experts
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
This approval has come from the company's finished dosage form manufacturing facility
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Subscribe To Our Newsletter & Stay Updated
